Literature summary for 2.1.1.8 extracted from

Tomita, Y; Yuno, A; Tsukamoto, H; Senju, S; Kuroda, Y; Hirayama, M; Imamura, Y; Yatsuda, J; Sayem, MA; Irie, A; Hamada, A; Jono, H; Yoshida, K; Tsunoda, T; Daigo, Y; Kohrogi, H; Yoshitake, Y; Nakamura, Y; Shinohara, M; Nishimura, Y
Identification of immunogenic LY6K long peptide encompassing both CD4(+) and CD8(+) T-cell epitopes and eliciting CD4(+) T-cell immunity in patients with malignant disease. (2014), Oncoimmunology, 3, e28100.

Organism

Organism	UniProt	Comment	Textmining

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)